Sign in to view content

Potential Safety Concerns of Bevacizumab for Retinopathy of Prematurity

Robert L. Avery, MD

Video
Published 2016

Related

Economic Impact of the Use of Anti-VEGF Monotherapy or in Combination With Panretinal Photocoagulation
Swati Agarwal-Sinha, MD, FASRS
Annual Meeting Talks
First Results From a Phase 1B Multiple-Dose Study of KSI-301: A Novel Anti-VEGF Antibody Biopolymer Conjugate (ABC) With Extended Durability
Pravin U. Dugel, MD
Annual Meeting Talks
2019
Suprachoroidal CLS-TA Plus Aflibercept Compared With Aflibercept Monotherapy for DME: Results of a Phase 2 Trial
Michael S. Ip, MD
Annual Meeting Talks
2019

Category: Pediatric Retina

See more